{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:23:59Z","timestamp":1781670239781,"version":"3.54.5"},"reference-count":80,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:p>Purpose: The clinical experience and role in therapy of colesevelam in type 2 diabetes mellitus (T2DM) is discussed. Summary: Colesevelam HCl is a bile acid sequestrant (BAS) with proven efficacy in reducing elevated low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia. Colesevelam HCl gained food and drug administration (FDA) approval in 2008 as an adjunct to diet and exercise to improve glycemic control in adults with T2DM. In randomized controlled studies, colesevelam (add-on therapy with metformin, sulfonylureas, and insulin) has shown significant percentage reductions in glycosylated hemoglobin A1c (HbA1c) ranging from 0.5% to 0.54%. Reductions in LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C) ranging from \u201312.8% to \u201316.7% and \u20134.0% to \u201310.3%, respectively, were also observed. Although no direct comparisons have been made, the safety and tolerability profile of this agent appears to be better than other BAS, with the most common side effects being gastrointestinal related. Conclusion: Colesevelam is effective as an adjunct to diet and exercise to improve glycemic control in adults with T2DM. Due to its effects upon LDL-C and glycemic parameters and favorable safety profile, colesevelam can play a role in an array of T2DM patients.<\/jats:p>","DOI":"10.1177\/0897190011406125","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T01:55:51Z","timestamp":1312422951000},"page":"417-425","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Efficacy of Colesevelam in Type 2 Diabetes Mellitus"],"prefix":"10.1177","volume":"24","author":[{"given":"Luigi","family":"Brunetti","sequence":"first","affiliation":[{"name":"Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, Piscataway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Keith","family":"Campbell","sequence":"additional","affiliation":[{"name":"Washington State University, Pullman, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,8,3]]},"reference":[{"key":"bibr1-0897190011406125","unstructured":"Centers for Disease Control and Prevention. 2007 Diabetes fact sheet. www.cdc.gov\/diabetes\/pubs\/factsheet07.htm. Accessed December 24, 2010."},{"key":"bibr2-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191261"},{"key":"bibr3-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9025"},{"key":"bibr4-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP.15.6.540"},{"key":"bibr5-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9017"},{"issue":"12","key":"bibr6-0897190011406125","first-page":"2545","volume":"358","author":"Gerstein HC","year":"2008","journal-title":"N Engl J Med"},{"key":"bibr7-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"bibr8-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"bibr9-0897190011406125","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-11-200906020-00008"},{"key":"bibr10-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b800"},{"key":"bibr11-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S011"},{"key":"bibr12-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2007.10.007"},{"key":"bibr13-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4065\/76.10.971"},{"key":"bibr14-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.16.1893"},{"key":"bibr15-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.08.037"},{"key":"bibr16-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240610"},{"key":"bibr17-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00437-3"},{"key":"bibr18-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00638-6"},{"key":"bibr19-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.039"},{"key":"bibr20-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X148436"},{"key":"bibr21-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.08.013"},{"key":"bibr22-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP.13.1.11"},{"key":"bibr23-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000155109.69831.a3"},{"key":"bibr24-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X59157"},{"key":"bibr25-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2007.09.001"},{"key":"bibr26-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.18.1975"},{"key":"bibr27-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0313-2"},{"key":"bibr28-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00903.x"},{"key":"bibr29-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1159\/000174548"},{"key":"bibr30-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198005293022202"},{"key":"bibr31-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1007\/BF03216291"},{"key":"bibr32-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.68.033104.152158"},{"key":"bibr33-0897190011406125","volume-title":"Paper presented at the 45th Annual Meeting of the European Association for the Study of Diabetes","author":"Beysen C","year":"2009"},{"key":"bibr34-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2782"},{"key":"bibr35-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0307"},{"key":"bibr36-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90233.2008"},{"key":"bibr37-0897190011406125","volume-title":"Paper presented at the 45th Annual Meeting of the European Association for the Study of Diabetes","author":"Xu G","year":"2009"},{"key":"bibr38-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199201000-00003"},{"key":"bibr39-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23831"},{"key":"bibr40-0897190011406125","unstructured":"Kuipers F, Murphy EJ. Effects of colesevelam hcl on bile acid kinetics. www.clinicaltrials.gov\/ct2\/show\/NCT00476710?term=colesevelam+HCl&rank=8. Accessed September 19, 2009."},{"key":"bibr41-0897190011406125","unstructured":"Vella A. The effect of colesevelam hydrochloride (hcl) on disposition index and incretin concentrations in subjects with type 2 diabetes. www.clinicaltrials.gov\/ct2\/show\/study\/NCT00951899?term=colesevelam+HCl&recr=Open&rank=2. Accessed September 19, 2009."},{"key":"bibr42-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767100-00001"},{"key":"bibr43-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e32830c6c37"},{"key":"bibr44-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1038\/nature05449"},{"key":"bibr45-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.74.338"},{"key":"bibr46-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.4.890"},{"issue":"16","key":"bibr47-0897190011406125","first-page":"11039","volume":"281","author":"Cariou B","year":"2006","journal-title":"J Biochem"},{"key":"bibr48-0897190011406125","first-page":"145","volume-title":"ADA\/PDR Medications for the Treatment of Diabetes","author":"Campbell K","year":"2008"},{"key":"bibr49-0897190011406125","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2009.11.2078"},{"key":"bibr50-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP10129.OR"},{"key":"bibr51-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP10130.OR"},{"key":"bibr52-0897190011406125","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-6-199409150-00004"},{"key":"bibr53-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0283"},{"key":"bibr54-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.14.1531"},{"key":"bibr55-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.01.003"},{"key":"bibr56-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1241195"},{"key":"bibr57-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP09146.OR"},{"key":"bibr58-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340270029025"},{"issue":"1","key":"bibr59-0897190011406125","first-page":"1","volume":"16","author":"Corsini A","year":"2009","journal-title":"Eur J Cardiol"},{"key":"bibr60-0897190011406125","unstructured":"Product information. Welchol (colesevelam hydrochloride) package insert. Parsippany, NJ: Daiichi Sankyo Inc, 2009 October."},{"key":"bibr61-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.11.022"},{"key":"bibr62-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10263"},{"key":"bibr63-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.10.008"},{"key":"bibr64-0897190011406125","unstructured":"Joslin Diabetes Center. Joslin Diabetes Center & Joslin Clinic clinical guideline for pharmacological management of type 2 diabetes 1\/09\/2009. www.joslin.org\/Files\/Clinical-Guidelines-for-Pharmacological-Management-of-Type2-Diabetes.pdf. Accessed November, 2009."},{"key":"bibr65-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.025"},{"key":"bibr66-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.20.2269"},{"key":"bibr67-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-6640-4"},{"key":"bibr68-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080330"},{"issue":"7","key":"bibr69-0897190011406125","first-page":"2644","volume":"302","author":"Kuehn BM","year":"2009","journal-title":"JAMA"},{"key":"bibr70-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.22.2634"},{"key":"bibr71-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"bibr72-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"},{"key":"bibr73-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1385"},{"key":"bibr74-0897190011406125","doi-asserted-by":"publisher","DOI":"10.4158\/EP09104.CRR"},{"key":"bibr75-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0058"},{"key":"bibr76-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1755"},{"key":"bibr77-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1089\/met.2009.0007"},{"key":"bibr78-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-5686-z"},{"key":"bibr79-0897190011406125","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M728"},{"key":"bibr80-0897190011406125","doi-asserted-by":"publisher","DOI":"10.2165\/11539600-000000000-00000"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190011406125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190011406125","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190011406125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:34:32Z","timestamp":1777509272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190011406125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1177\/0897190011406125"],"URL":"https:\/\/doi.org\/10.1177\/0897190011406125","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}